Altman Z-Score:
9.55+0.18(+1.92%)Summary
- As of today (September 15, 2025), CRSP Altman Z-Score is 9.55, with the most recent change of +0.18 (+1.92%) on September 15, 2025.
- CRSP current Altman Z-Score indicates the stock has a low bankruptcy risk.
Performance
CRSP Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
CRSP Altman Z-Score Trends
| PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market capMarket cap |
|---|---|---|---|
| todaytoday | +1.9% | +1.8% | +1.8% |
| 1 m1 month | -4.3% | -4.2% | -4.2% |
| 3 m3 months | +49.7% | +38.4% | +45.8% |
| 6 m6 months | +47.1% | +35.9% | +43.4% |
| ytdytd | +59.2% | +45.4% | +54.3% |
| 1 y1 year | +29.2% | +17.0% | +24.9% |
| 5 y5 years | -67.3% | -32.6% | -12.6% |
CRSP Altman Z-Score History
| Date | Value |
|---|---|
| 2025 | 9.55(+59.2%) |
| 2024 | 6.00(-32.2%) |
| 2023 | 8.85(+91.6%) |
| 2022 | 4.62(-60.2%) |
| 2021 | 11.62(-72.0%) |
| Date | Value |
|---|---|
| 2020 | 41.46(+123.1%) |
| 2019 | 18.58(+122.2%) |
| 2018 | 8.36(+26.7%) |
| 2017 | 6.60(+32.3%) |
| 2016 | 4.99 |
FAQ
- What is CRISPR Therapeutics AG altman z-score?
- What is CRSP altman z-score year-to-date change?
- What is CRISPR Therapeutics AG altman z-score year-on-year change?
What is CRISPR Therapeutics AG altman z-score?
The current altman z-score of CRSP is 9.55
What is CRSP altman z-score year-to-date change?
CRISPR Therapeutics AG altman z-score has changed by +3.55 (+59.17%) since the beginning of the year
What is CRISPR Therapeutics AG altman z-score year-on-year change?
Over the past year, CRSP altman z-score has changed by +2.16 (+29.23%)